Statins and Atherosclerotic Lesion Microcalcification: A New Mechanism for Plaque Stability?
作者信息
Doran Amanda C, Terry James G, Carr John Jeffrey, Linton MacRae F
机构信息
Division of Cardiovascular Medicine, Department of Medicine (A.C.D., J.J.C., M.F.L.), Vanderbilt University Medical Center, Nashville, TN.
Vanderbilt Institute for Infection, Immunology, and Inflammation (A.C.D.), Vanderbilt University Medical Center, Nashville, TN.
出版信息
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1306-1308. doi: 10.1161/ATVBAHA.121.315949. Epub 2021 Mar 24.
Abstract
摘要
相似文献
1
Statins and Atherosclerotic Lesion Microcalcification: A New Mechanism for Plaque Stability?他汀类药物与动脉粥样硬化病变微钙化：斑块稳定性的新机制？
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1306-1308. doi: 10.1161/ATVBAHA.121.315949. Epub 2021 Mar 24.
2
Statins Disrupt Macrophage Rac1 Regulation Leading to Increased Atherosclerotic Plaque Calcification.他汀类药物破坏巨噬细胞 Rac1 调节导致动脉粥样硬化斑块钙化增加。
Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):714-732. doi: 10.1161/ATVBAHA.119.313832. Epub 2020 Jan 30.
3
Plaque Calcification During Atherosclerosis Progression and Regression.动脉粥样硬化进展和消退过程中的斑块钙化。
J Atheroscler Thromb. 2018 Apr 1;25(4):294-303. doi: 10.5551/jat.RV17020. Epub 2017 Dec 12.
4
Atorvastatin Promotes Macrocalcification, But Not Microcalcification in Atherosclerotic Rabbits: An 18F-NaF PET/CT Study.阿托伐他汀促进动脉粥样硬化兔的大钙化，但不促进微钙化：一项 18F-NaF PET/CT 研究。
J Cardiovasc Pharmacol. 2021 Oct 1;78(4):544-550. doi: 10.1097/FJC.0000000000001088.
5
Effects of Statins on Coronary Atherosclerotic Plaques: The PARADIGM Study.他汀类药物对冠状动脉粥样硬化斑块的影响：PARADIGM 研究。
JACC Cardiovasc Imaging. 2018 Oct;11(10):1475-1484. doi: 10.1016/j.jcmg.2018.04.015. Epub 2018 Jun 13.
6
Statin Effects on Vascular Calcification: Microarchitectural Changes in Aortic Calcium Deposits in Aged Hyperlipidemic Mice.他汀类药物对血管钙化的影响：老年高脂血症小鼠主动脉钙沉积的微观结构变化。
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):e185-e192. doi: 10.1161/ATVBAHA.120.315737. Epub 2021 Jan 21.
7
Liquid Biopsy of Extracellular Microvesicles Maps Coronary Calcification and Atherosclerotic Plaque in Asymptomatic Patients With Familial Hypercholesterolemia.液体活检细胞外囊泡可描绘无症状家族性高胆固醇血症患者的冠状动脉钙化和动脉粥样硬化斑块。
Arterioscler Thromb Vasc Biol. 2019 May;39(5):945-955. doi: 10.1161/ATVBAHA.118.312414.
8
Differential association between the progression of coronary artery calcium score and coronary plaque volume progression according to statins: the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging (PARADIGM) study.根据他汀类药物的不同，冠状动脉钙评分进展与冠状动脉斑块体积进展之间的关联存在差异：由计算机断层血管造影成像确定的动脉粥样硬化斑块进展研究（PARADIGM 研究）。
Eur Heart J Cardiovasc Imaging. 2019 Nov 1;20(11):1307-1314. doi: 10.1093/ehjci/jez022.
9
Statins association with calcification in coronary plaque and heart valves: a possible different clinical significance: Montignoso HEart and Lung Project (MHELP) study preliminary data in primary cardiovascular prevention.他汀类药物与冠状动脉斑块和心脏瓣膜钙化的关联：一种可能不同的临床意义：蒙蒂尼奥索心脏与肺部项目（MHELP）在原发性心血管预防中的研究初步数据
Eur J Prev Cardiol. 2021 Jul 23;28(8):e15-e17. doi: 10.1177/2047487320932330.
10
Impact of statins on serial coronary calcification during atheroma progression and regression.他汀类药物对动脉粥样硬化进展和消退过程中冠状动脉钙化的影响。
J Am Coll Cardiol. 2015 Apr 7;65(13):1273-1282. doi: 10.1016/j.jacc.2015.01.036.
引用本文的文献
1
The Complex Mechanisms and the Potential Effects of Statins on Vascular Calcification: A Narrative Review.他汀类药物对血管钙化的复杂机制及潜在影响：一项叙述性综述
Rev Cardiovasc Med. 2024 Jan 30;25(2):51. doi: 10.31083/j.rcm2502051. eCollection 2024 Feb.
2
Causal association between triglycerides and cholesterol-lowering medication with non-rheumatic valve disease: A 2-sample Mendelian randomization study.三酰甘油与非风湿性瓣膜病患者降胆固醇药物之间的因果关系：两样本 Mendelian 随机研究。
Medicine (Baltimore). 2024 Jul 19;103(29):e38971. doi: 10.1097/MD.0000000000038971.
3
Similarities and Differences of Vascular Calcification in Diabetes and Chronic Kidney Disease.糖尿病与慢性肾脏病中血管钙化的异同
Diabetes Metab Syndr Obes. 2024 Jan 10;17:165-192. doi: 10.2147/DMSO.S438618. eCollection 2024.
4
Vitamin K and Calcium Chelation in Vascular Health.维生素K与血管健康中的钙螯合作用
Biomedicines. 2023 Nov 27;11(12):3154. doi: 10.3390/biomedicines11123154.
5
Coronary Artery Calcium in Assessment of Atherosclerotic Cardiovascular Disease Risk and its Role in Primary Prevention.冠状动脉钙在动脉粥样硬化性心血管疾病风险评估及其在一级预防中的作用。
J Atheroscler Thromb. 2023 Oct 1;30(10):1289-1302. doi: 10.5551/jat.RV22009. Epub 2023 Jul 1.
本文引用的文献
1
Innate and adaptive immunity in cardiovascular calcification.先天性和适应性免疫在心血管钙化中的作用。
Atherosclerosis. 2020 Aug;306:59-67. doi: 10.1016/j.atherosclerosis.2020.02.016. Epub 2020 Feb 28.
2
Pravastatin polarizes the phenotype of macrophages toward M2 and elevates serum cholesterol levels in apolipoprotein E knockout mice.普伐他汀可使巨噬细胞表型向M2极化，并升高载脂蛋白E基因敲除小鼠的血清胆固醇水平。
J Int Med Res. 2018 Aug;46(8):3365-3373. doi: 10.1177/0300060518787671. Epub 2018 Jul 29.
3
Effects of Statins on Coronary Atherosclerotic Plaques: The PARADIGM Study.他汀类药物对冠状动脉粥样硬化斑块的影响：PARADIGM 研究。
JACC Cardiovasc Imaging. 2018 Oct;11(10):1475-1484. doi: 10.1016/j.jcmg.2018.04.015. Epub 2018 Jun 13.
4
Coronary Artery Calcification and its Progression: What Does it Really Mean?冠状动脉钙化及其进展：它到底意味着什么？
JACC Cardiovasc Imaging. 2018 Jan;11(1):127-142. doi: 10.1016/j.jcmg.2017.10.012.
5
Association of Coronary Artery Calcium in Adults Aged 32 to 46 Years With Incident Coronary Heart Disease and Death.32 至 46 岁成年人的冠状动脉钙与冠心病事件和死亡的关系。
JAMA Cardiol. 2017 Apr 1;2(4):391-399. doi: 10.1001/jamacardio.2016.5493.
6
Intra-Section Analysis of Human Coronary Arteries Reveals a Potential Role for Micro-Calcifications in Macrophage Recruitment in the Early Stage of Atherosclerosis.人类冠状动脉的节段内分析揭示了微钙化在动脉粥样硬化早期巨噬细胞募集过程中的潜在作用。
PLoS One. 2015 Nov 10;10(11):e0142335. doi: 10.1371/journal.pone.0142335. eCollection 2015.
7
Has our understanding of calcification in human coronary atherosclerosis progressed?我们对人冠状动脉粥样硬化中的钙化的理解是否有所进展？
Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):724-36. doi: 10.1161/ATVBAHA.113.302642. Epub 2014 Feb 20.
8
Calcium density of coronary artery plaque and risk of incident cardiovascular events.冠状动脉斑块钙密度与心血管事件发生风险。
JAMA. 2014 Jan 15;311(3):271-8. doi: 10.1001/jama.2013.282535.
9
Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.新型风险标志物在改善中危人群心血管风险评估中的比较。
JAMA. 2012 Aug 22;308(8):788-95. doi: 10.1001/jama.2012.9624.
10
Coronary artery calcium progression: an important clinical measurement? A review of published reports.冠状动脉钙进展：重要的临床测量指标？对已发表报告的综述。
J Am Coll Cardiol. 2010 Nov 9;56(20):1613-22. doi: 10.1016/j.jacc.2010.06.038.
Zotero 插件